About this trial
The prevalence of refractive ametropia is rising year by year. Refractive surgery has become the main approach for adults to correct refractive ametropia, and postoperative complications have aroused extensive attention from clinicians. Dry eye after refractive surgery is one of the postoperative complications, which is an important cause of affecting the postoperative visual quality and satisfaction of patients. It was reported that 3% diquafosol (DQS) and 0.1% hyaluronic acid (HA) can relieve dry eye symptoms. This study aims to compare the efficacy of 3% DQS and 0.1% HA in treating dry eye after LASIK
Eligibility criteria
Qualifiers
History of LASIK surgery for more than six months
Confirmed dry eye: patients complained of one of the subjective symptoms of ocular dryness, foreign body sensation, burning sensation, fatigue, discomfort, redness of the eyes, and fluctuating visual acuity; as well as (a) OSDI questionnaire score of ≥13 and (b) non-invasive tear break-up time (NITBUT) of <10 s or (c) ocular surface staining assessed in >5 corneal patches/greater than 9 conjunctival patches
Participants were able to co-operate with the use of eye drops as required, complete the examination, and return to the hospital within the specified time for follow-up examinations to complete the follow-up visit.
Disqualifiers
Suspected of having keratoconus, a definite diagnosis of keratoconus or another type of corneal dilatation disease.
There is active inflammation or symptoms of infection in the eye
There are serious lesions in the accessory structures of the eye, such as defects or deformations of the eyelids
Patients with Connective tissue diseases and Autoimmune disorders (e.g., SLE, RA)
Trial design
Treatments tested in this trial
- 3% Diquafosol Sodium Eye Drops
- 0.1% hyaluronic acid